Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

chemotherapy

  • Open Access
    Rapid Eradication of Extensive Spinal Metastases in a Prostate-Cancer Patient Taking Androgen-deprivation Therapy, Chemotherapy, and Oral Recombinant Methioninase on a Low-Methionine Diet
    YOHEI ASANO, QINGHONG HAN, SHUKUAN LI, TOSHIHIKO SATO, CHIHIRO HOZUMI, BYUNG MO KANG, JIN SOO KIM, YUTA MIYASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, SEI MORINAGA, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research December 2025, 45 (12) 5799-5805; DOI: https://doi.org/10.21873/anticanres.17912
  • Open Access
    Focused Ultrasound-mediated Disruption of Plasma Protein Binding Enhances Chemotherapeutic Effects of Paclitaxel on Xenografted Ovarian Cancer in Mice
    SEUNG-SCHIK YOO, KATHRYN BANISH, ABDUELRAHMAN FAHMI, CAROLYN GLASENER, KYUNGHO YOON, SWATI BETHARIA, YONGZHI ZHANG, KEVIN ELIAS and NEIL HOROWITZ
    Anticancer Research November 2025, 45 (11) 4697-4715; DOI: https://doi.org/10.21873/anticanres.17820
  • Open Access
    Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell Lines
    MADELEINE BIRGERSSON, TERÉZIA CHABANOVÁ, EMILIA WIECHEC, OURANIA N. KOSTOPOULOU and TINA DALIANIS
    Anticancer Research November 2025, 45 (11) 4729-4742; DOI: https://doi.org/10.21873/anticanres.17822
  • Open Access
    Osteosarcoma of the Diaphysis: A Report from the Cooperative Osteosarcoma Study Group (COSS)
    STEFAN S. BIELACK, CLAUDIA BLATTMANN, LEO KAGER, DANIEL BAUMHOER, ARNDT BORKHARDT, TOBIAS FEUCHTINGER, GODEHARD FRIEDEL, JENDRIK HARDES, SEMI BEN HARRABI, WOLF HASSENPFLUG, THEKLA VON KALLE, MATTHIAS KEVRIC, ANTONIA KNOLL, THOMAS KÜHNE, CLAUDIA ROSSIG, BENJAMIN SORG, MATHIAS WERNER, REINHARD WINDHAGER and STEFANIE HECKER-NOLTING
    Anticancer Research November 2025, 45 (11) 5031-5043; DOI: https://doi.org/10.21873/anticanres.17844
  • Open Access
    Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase
    YOHEI ASANO, QINGHONG HAN, SHUKUAN LI, KOHEI MIZUTA, BYUNG MO KANG, JIN SOO KIM, YUTA MIYASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, SEI MORINAGA, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research November 2025, 45 (11) 5225-5231; DOI: https://doi.org/10.21873/anticanres.17862
  • Open Access
    Dose-dependent Efficacy of Olanzapine for Chemotherapy-induced Nausea and Vomiting: A Systematic Review and Meta-analysis
    RIKA UCHINO and YUMA SHIBUTANI
    Anticancer Research September 2025, 45 (9) 3605-3616; DOI: https://doi.org/10.21873/anticanres.17725
  • Open Access
    Management of Chemotherapy-induced Oral Mucositis in Gastrointestinal Malignancies: Evidence From Randomized Controlled Trails
    TORU AOYAMA, HARUHIKO CHO and HIDEAKI SUEMATSU
    Anticancer Research August 2025, 45 (8) 3175-3181; DOI: https://doi.org/10.21873/anticanres.17680
  • Open Access
    Immunotherapy and Chemotherapy for Advanced or Recurrent Endometrial Carcinoma
    JOHN P. MICHA, RANDY D. BOHART, JOSHUA P. GORMAN and BRAM H. GOLDSTEIN
    Anticancer Research July 2025, 45 (7) 2711-2717; DOI: https://doi.org/10.21873/anticanres.17641
  • You have access
    Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB HER2-negative Gastric Cancer
    YUDAI HOJO, TOSHIHIKO TOMITA, MASATAKA IGETA, MOTOKI MURAKAMI, SHUGO KOHNO, EIICHIRO NAKAO, YOSHITAKA KITAYAMA, TATSURO NAKAMURA, YASUNORI KURAHASHI, YOSHINORI ISHIDA, SEIICHI HIROTA, SHINICHIRO SHINZAKI and HISASHI SHINOHARA
    Anticancer Research May 2025, 45 (5) 2091-2102; DOI: https://doi.org/10.21873/anticanres.17583
  • You have access
    Palliative Radiotherapy for Large Osteolytic Metastatic Tumors Involving the Iliac Bone: A Report of 16 Cases
    FEDERICO AMPIL, RUSSELL ANDERSON, TROY RICHARDS, CARRIE PORTER and MICHELLE NORTON
    Anticancer Research May 2025, 45 (5) 2103-2108; DOI: https://doi.org/10.21873/anticanres.17584

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 41
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire